MAPT and diabetes mellitus: In the db/db mouse model of diabetes, metformin inhibited the increase of total tau, phosphorylated tau and activated c-jun N-terminal kinase (a tau kinase), and mitigated the decrease of synaptophysin in the hippocampus [119].